|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02500 VENUS MEDTECH-B
Nominal 
5.620 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 230,720 | -9.737% | 491,373 | 406,461 | 415,862 | 276,047 |
| Cost of Sales | (48,960) | -9.935% | (102,168) | (92,463) | (91,518) | (48,767) |
| Gross Profit | 181,760 | -9.684% | 389,205 | 313,998 | 324,344 | 227,280 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 764 | -- | 2,210 | (21,972) | (3,185) | 50 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (641) | -90.796% | (12,381) | (13,943) | (11,711) | 570 | |
| Profit / (Loss) before Taxation | (213,581) | -42.328% | (735,340) | (1,156,344) | (377,555) | (185,843) | |
| Taxation | 4,756 | 15.325% | 6,284 | 34,302 | 6,161 | 2,975 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,338 | -85.412% | 25,302 | 64,343 | (2,242) | 879 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (206,487) | -41.035% | (703,754) | (1,057,699) | (373,636) | (181,989) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,805 | -68.559% | 28,259 | 9,975 | (47,575) | (30,495) |
| Depreciation & Amortisation | 58,490 | 4.342% | 124,787 | 112,352 | 51,621 | 37,712 |
| Directors' Emoluments | -- | -- | 3,905 | 4,539 | 4,478 | 3,841 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -47.000 | -41.250% | -165.000 | -242.000 | -85.000 | -45.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (1.393) | (1.666) | (1.042) | (0.579) |
| NBV per share ($) | 6.180 | -- | 6.623 | 8.181 | 10.307 | 9.021 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -206,487,000 |
| %Change | -41.035% |
| EPS / (LPS) | RMB -0.470 |
| NBV Per Share (¥) | RMB 6.180 |